You are here
P&T March 2013
Among the health care changes this year: revenues to hospitals will be lower, payments to physicians will be modified, and more patients will be covered by Medicaid.
it is unclear how the final rule on “clinically appropriate” and “medically necessary” drugs will apply to hospital formularies and Part B drugs given in the doctor’s office.
The author presents 4 case histories of patients who experienced angioedema after treatment with various ACE inhibitors in what some have called a “silent epidemic.”
FDA approvals, drug indications, and updates
Bedaquiline for multiresistant pulmonary tuberculosis; Flublok influenza vaccine; and Octaplas for coagulation factor deficiency